Thermo Fisher Scientific | TMO - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Abbott USD 6.47B 525M 2026-09
Agilent USD 836M 9M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Boston Scientific USD 1.96B 93M 2026-09
Bruker USD 422.5M 21.1M 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Danaher USD 2.72B 63M 2026-09
Dentsply International USD 405M 48M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
General Electric Aerospace USD 9.33B 439M 2026-09
Henry Schein USD 2.43B 129M 2026-06
Illumina USD 389M 19M 2026-06
Intuitive Surgical USD 964.4M 32.5M 2026-09
IQVIA Holdings USD 3.25B 26M 2026-09
Laboratory Of America USD 2.78B 83.4M 2026-09
Medtronic USD 3.83B 26M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Olympus JPY 83.57B 18.95B 2026-06
OraSure Technologies USD 15.43M 113K 2025-12
Quest Diagnostics USD 2.09B 38M 2026-09
Repligen USD 98.33M 4.24M 2026-09
Revvity USD 312.82M 10.64M 2026-06
Stryker USD 2.26B 106M 2026-06
Thermo Fisher Scientific USD 7.46B 72M 2026-09
Veracyte USD 42.19M 3.7M 2026-06
Waters USD 1.16B 430M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06